Q1 2017
Released May 8, 2017, before the open
10-Q filed May 8, 2017, 38 days after period end · 0001144204-17-024980
Q1 2017 · 10-Q
Revenue$0.00$0.00 no prior Q1 2016 on fileno prior Q4 2016 on file
Net Income-$4.86M-$4.86M N/M vs Q1 2016N/M vs Q4 2016
EPS Diluted-$0.26-$0.26 N/M vs Q1 2016N/M vs Q4 2016
Operating Income-$4,908,915N/M
Operating Cash Flow-$3,138,751N/M
Free Cash Flowderived-$3,138,751N/M
What the release said
The release
Same quarter
| Metric | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 |
|---|---|---|---|---|
| Revenue | $0.00 | — | — | — |
| Net Income | -$4.86M | -$7.01M | -$2.96M | -$5.27M |
| EPS Diluted | -$0.26 | -$0.38 | -$0.23 | -$0.41 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR